Just like racing, in my cancer world, I need to get the research car in the best position possible before I turn it over to the closing driver – maybe that’s NIH, a drug company, or someone else. But we have to build momentum if we want a chance to win. That’s why I’m working and investing in the early stages  of the research race.

Only focusing on one or two legs doesn’t get us where we need to be as fast as needed. This is kind of how cancer treatment development and research works. Think of it like a cancer relay race.

Be cautious if reading or listening to news from international outlets, understand the rules they are playing by.

If you’re doing business in another county, you need to understand the rules and comply.

Foundation does things differently, and after 10+ years of making contributions, I know our process works. Let me share how you can maximize your contribution dollars.

In this episode, Macklin and Giovanis discuss the power of math and collaboration in cancer research.

A promising study shows that certain may more safely help detect and treat cancer. Researchers tested several types of tiny iron oxide particles—similar to those already approved by the FDA for other uses—to see how they affect the body and where they travel after injection.

2025 Symposium: Improving Breast Cancer Outcomes // Revealing and Targeting Immune Interaction

JKTG-funded project aims to answer question: Why do cancer cells selectively colonize in the liver?